Source: International Congress 2018 – Biomarkers of COPD and asthma-COPD overlap syndrome (ACOS)
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
J. Shim (Seoul, Republic of Korea), J. Oh (Seoul, Republic of Korea), J. Choi (Seoul, Republic of Korea), Y. Lee (Seoul, Republic of Korea), K. Min (Seoul, Republic of Korea), G. Hur (Seoul, Republic of Korea), S. Lee (Seoul, Republic of Korea), K. Kang (Seoul, Republic of Korea). Increased urinary l-histidine in patients with asthma–chronic obstructive pulmonary disease overlap. 5470

Member's Comments

No comment yet.

Related content which might interest you: Is increased gastro-intestinal permeability related to exacerbation in patients with chronic obstructive pulmonary disease? Source: Virtual Congress 2020 – Air pollution and comorbidities Year: 2020 High interleukin-33 is associated with acute exacerbation in patients with chronic obstructive pulmonary disease Source: Virtual Congress 2020 – Prediction of outcomes in obstructive diseases Year: 2020 Prevalence of bronchiectasis in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2006; 28: Suppl. 50, 60s Year: 2006 The impact of using different symptom-based exacerbation algorithms in patients with COPD Source: Eur Respir J 2011; 37: 1260-1268 Year: 2011 Home hospitalisation of exacerbated chronic obstructive pulmonary disease patients Source: Eur Respir J 2003; 21: 58-67 Year: 2003 A comparison of airways resistance and spirometry in patients with acute exacerbations of chronic obstructive pulmonary disease Source: Annual Congress 2010 - COPD: treatment and monitoring Year: 2010 The characteristic of chronic renal dysfunction in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 Similarities and differences between patients with chronic obstructive pulmonary disease and/or bronchiectasis Source: Annual Congress 2010 - Bronchiectasis and respiratory infections caused by Pseudomonas Year: 2010 The safety of sputum induction in patients with exacerbation of severe and very severe COPD (chronic obstructive pulmonary disease) Source: Annual Congress 2008 - Organisation of care and management of COPD Year: 2008 IL-8 in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 364s Year: 2001 Frequency of depressive syndrome in patients with bronchial asthma and chronic obstructive pulmonary disease Source: Virtual Congress 2021 – Pulmonary rehabilitation in clinical conditions Year: 2021 Definition and differential diagnosis of chronic obstructive pulmonary disease Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=1 Year: 2006 Determinants of depression at exacerbation in chronic obstructive pulmonary disease Source: Eur Respir J 2007; 30: Suppl. 51, 557s Year: 2007 Similarities and differences in asthma and chronic obstructive pulmonary disease exacerbations Source: Annual Congress 2008 - PG17 - An expert view of the differences between asthma and COPD Year: 2008 Airways obstruction is associated with increased cardiac injury and systemic inflammation in patients with stable COPD Source: Annual Congress 2006 - COPD and systemic inflammation Year: 2006 Inferon administration to patients with chronic obstructive pulmonary disease Source: Annual Congress 2009 - Pathological remodelling in chronic lung disease: from epithelial-mesenchymal transition to cellular activation Year: 2009 Are severe asthma and chronic obstructive pulmonary disease the same disease? Source: Annual Congress 2006 - Smoking asthmatics – a neglected population? Year: 2006 Comparison of serum osteopontin levels in patients with exacerbations and stable chronic obstructive pulmonary disease Source: Annual Congress 2012 - Cell biology, blood and sputum biomarkers in airway diseases Year: 2012 Prevalence of comorbidity in patients with chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: Suppl. 33, 209s Year: 2001 Systemic effects of chronic obstructive pulmonary disease Source: Eur Respir J 2003; 21: 347-360 Year: 2003